CLOBAZAM
Generic: CLOBAZAM
Sun Pharmaceutical IndustriesManufacturer
ORALRoute
CLOBAZAMActive Substance
2019-04-15Original Approval
CLOBAZAM is FDA application ANDA210978, sponsored by TARO. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-01-07
Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLPresence of Foreign Tablets/Capsules
Class II2024-12-13
Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLPresence of Foreign Tablets/Capsules
Class II2019-07-16
Clobazam Oral Suspension, 2.5 mg/mL, 120 mL bottle, Rx only, Distributed by: Bionpharma Inc., 600 Alexander Road, PrinceMicrobial Contamination of Non-Sterile Products: Out-of-specification results for Microbial Enumerat
Class II2024-02-12
Clobazam Tablets 10mg, 100-count bottle, Rx Only, Manufactured by: Micro Labs Limited Goa-403 722, India. Manufactured fCGMP Deviations: Out of specification for residual solvents.
Top Reported Reactions
1
SEIZURE
3,049 reports
2
DRUG INEFFECTIVE
2,709 reports
3
OFF LABEL USE
1,939 reports
4
SOMNOLENCE
1,348 reports
5
DRUG INTERACTION
1,057 reports
6
EPILEPSY
810 reports
7
CONDITION AGGRAVATED
760 reports
8
FATIGUE
739 reports
9
STATUS EPILEPTICUS
624 reports
10
MULTIPLE-DRUG RESISTANCE
584 reports